Mixed reality and holographic technologies to deliver cognitive and behavioural therapies for the treatment of symptoms of anxiety among teenagers with asthma
- Conditions
- AsthmaPsychological distressRespiratory - AsthmaMental Health - Other mental health disorders
- Registration Number
- ACTRN12620001109998
- Lead Sponsor
- niversity of South Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion criteria for young people: Young people will be eligible for inclusion in this study if they: are aged between 13 and 17 years; have been formally diagnosed with asthma by a health professional (inpatients or outpatients); have experienced or are currently experiencing heightened symptoms of psychological distress determined by the K10+ scale; have access to a smartphone with the owner’s permission to use it; are English speaking/able to understand written English.
Inclusion criteria for caregivers/parents: Participants will be eligible for inclusion in this study if they: are the caregiver/parent of a child with asthma (aged 13 to 17 years) who currently has/or has reported in the past heightened symptoms of psychological distress (does not need to be the parent/caregiver of a child actively participating in this study); have access to a smartphone and able to use smartphone technology (basic level); are English speaking/able to understand written English.
Inclusion criteria for health professionals: Health professionals will be eligible for inclusion in this study if they: have been practicing in their respective fields for at least 12-months; have access to a smartphone and are able to use smartphone technology (basic level); are English speaking/able to understand written English.
Participants with an intellectual disability or cognitive impairment that would inhibit their ability to provide informed consent and participate in the project will be ineligible to participate. Young people with a history of epilepsy or other contraindication for the use of VR will also be ineligible to participate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method